Mosunetuzumab Is Efficacious And Well Tolerated In Patients Aged <65 And >=65 Years With Relapsed/Refractory Follicular Lymphoma And >=2 Prior Therapies: Subgroup Analysis Of A Pivotal Phase Ii Study
Mosunetuzumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Mosunetuzumab Is Efficacious And Well Tolerated In Patients Aged <65 And >=65 Years With Relapsed/Refractory Follicular Lymphoma And >=2 Prior Therapies: Subgroup Analysis Of A Pivotal Phase Ii Study ### Output: Mosunetuzumab